For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Cytomed, Inc.

USPTO Granted Patents = 17

Forward Citations = 575

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Xiong Cai (13 out of 73 patents)

Sajjat Hussoin (9 out of 14 patents)

T Y Shen (7 out of 13 patents)

4. Tesfaye Biftu (6 out of 84 patents)

5. San-Bao Hwang (5 out of 5 patents)

6. David Killian (5 out of 5 patents)

7. Ralph Scannell (4 out of 7 patents)

8. Gurmit Grewal (4 out of 13 patents)

9. Aberra Fura (4 out of 6 patents)

10. Changgeng Qian (2 out of 51 patents)

11. Jone-Long Ko (2 out of 2 patents)

12. C Grace Yeh (2 out of 2 patents)

13. Karl Henry Nocka (1 out of 8 patents)

14. Saijat Hussoin (1 out of 1 patent)

15. Edward H Cohen (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 6294574 - Compounds and methods for the treatment of inflammatory and immune disorders (2001-09-25),

2. 6201016 - Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders (2001-03-13),

3. 5856323 - Compounds and methods for the treatment of disorders mediated by (1999-01-05),

4. 5851528 - Methods of inhibiting complement activation (1998-12-22),

5. 5792776 - Compounds and methods for the treatment of cardiovascular, inflammatory (1998-08-11),

6. 5780503 - Compounds and methods for the treatment of cardiovascular, inflammatory (1998-07-14),

7. 5750565 - Compounds and methods for the treatment of cardiovascular, inflammatory (1998-05-12),

8. 5741809 - Compounds and methods for the treatment of cardiovascular inflammatory (1998-04-21),

9. 5703093 - Compounds and methods for the treatment of cardiovascular, inflammatory (1997-12-30),

10. 5681966 - Compounds and methods for the treatment of cardiovascular, inflammatory (1997-10-28),

11. 5679546 - Chimeric proteins which block complement activation (1997-10-21),

12. 5648486 - Compounds and methods for the treatment of inflammatory and immune (1997-07-15),

13. 5525708 - Covalent dimer of kit ligand (1996-06-11),

14. 5468612 - 9804 gene and methods of use thereof (1995-11-21),

15. 5463083 - Compounds and methods for the treatment of cardiovascular, inflammatory (1995-10-31),

Company Overview

Cytomed, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapies for various medical conditions. The organization focuses on harnessing advanced cellular and molecular technologies to create solutions that address unmet medical needs. With a commitment to research and development, Cytomed aims to advance the field of regenerative medicine and improve patient outcomes through its cutting-edge therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

17 Patents

#158 in Cambridge, MA

#1,151 in Massachusetts

#18,903 in US

#35,948 in the World

Cambridge, MA, United States of America

Cytomed, Inc.

Forward Citations = 575

19 inventors:

Xiong Cai (13 out of 73 patents)

Sajjat Hussoin (9 out of 14 patents)

T Y Shen (7 out of 13 patents)

4. Tesfaye Biftu (6 out of 84 patents)

5. San-Bao Hwang (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytomed, Inc.. Retrieved from https://idiyas.com/company/cytomed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…